List of works - Hubert Zatorski

Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study

scientific article published on 22 August 2020

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice

scientific article published on 15 May 2021

Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations

scientific article published on 19 April 2019

Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review

scientific article

Colonic inflammation induces changes in glucose levels through modulation of incretin system

scientific article published in December 2021

Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.

scientific article

Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice

scientific article published on 21 August 2020

Development of the rectal dosage form with silver-coated glass beads for local-action applications in lower sections of the gastrointestinal tract

scientific article published on 31 July 2017

Evaluation of anti-inflammatory effect of silver-coated glass beads in mice with experimentally induced colitis as a new type of treatment in inflammatory bowel disease

scientific article published on 12 January 2017

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

scientific article

Experimental colitis in mice is attenuated by topical administration of chlorogenic acid

scientific article published on 7 March 2015

Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists

scientific article published on 23 February 2017

Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases

scientific article published on 17 March 2015

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

scientific article published on 25 October 2018

High activity of the endogenous opioid system and acute but not chronic stress influence experimental colitis development in mice

scientific article published on 01 October 2018

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

scientific article published on 14 July 2017

Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

scientific article published on 18 March 2016

Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.

scientific article published on 7 December 2017

Rhenium-coated glass beads for intracolonic administration attenuate TNBS-induced colitis in mice: Proof-of-Concept Study

scientific article published in January 2015

Role of environmental pollution in irritable bowel syndrome

scientific article

Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives

scientific article published on 29 July 2019

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.

scientific article

Silver and other metals in the treatment of gastrointestinal diseases

scientific article published on October 2015

Synthesis and evaluation of anti-inflammatory properties of silver nanoparticle suspensions in experimental colitis in mice

scientific article published on 02 November 2016

What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine

scientific article published on 10 July 2014

Young GI angle: The role of bibliometrics in scientist's career development

scientific article published in December 2017

List of works by Hubert Zatorski

Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice

Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations

Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review

Colonic inflammation induces changes in glucose levels through modulation of incretin system

Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.

Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice

Development of the rectal dosage form with silver-coated glass beads for local-action applications in lower sections of the gastrointestinal tract

Evaluation of anti-inflammatory effect of silver-coated glass beads in mice with experimentally induced colitis as a new type of treatment in inflammatory bowel disease

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

Experimental colitis in mice is attenuated by topical administration of chlorogenic acid

Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists

Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

High activity of the endogenous opioid system and acute but not chronic stress influence experimental colitis development in mice

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.

Rhenium-coated glass beads for intracolonic administration attenuate TNBS-induced colitis in mice: Proof-of-Concept Study

Role of environmental pollution in irritable bowel syndrome

Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.

Silver and other metals in the treatment of gastrointestinal diseases

Synthesis and evaluation of anti-inflammatory properties of silver nanoparticle suspensions in experimental colitis in mice

What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine

Young GI angle: The role of bibliometrics in scientist's career development